Papers
49
Total Citations
919
H-Index
19
About
Marco Sandri is a leading urologic surgeon and researcher whose work centers on advancing robotic surgery for prostate and kidney cancers. His most impactful contributions stem from the CLOCK trial, a landmark multicenter randomized controlled trial comparing on- versus off-clamp robotic partial nephrectomy; this work, cited over 100 times, has provided crucial data on renal function preservation and surgical safety. Sandri has also developed novel predictive tools for prostate cancer, including a nomogram and a statistical model for estimating extracapsular extension, enabling safer, more precise nerve-sparing during radical prostatectomy. His research extends to optimizing perioperative outcomes, such as using transversus abdominis plane blocks to reduce pain and narcotic use after robotic prostatectomy. With multiple papers garnering 30–100+ citations, Sandri’s work has shaped clinical guidelines and surgical decision-making. He has also analyzed the impact of PSA screening policy changes on oncological outcomes, demonstrating a decade-long perspective on prostate cancer management. Through rigorous clinical trials and predictive analytics, Sandri continues to refine robotic urologic surgery, improving both functional recovery and oncologic control for patients.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5A novel nomogram for predicting ECE of prostate cancer44 citations · 2018
- 6
- 7
- 8
- 9
- 10